Cancer / Oncology
Australian World First Paediatric mRNA Brain Cancer Trial Signals Expansion Opportunity For Canada And The United States
Landmark Australian study opens new possibilities for children with aggressive brain tumors and signals opportunity for Canada and USA. -- Providence Ther...
February 06, 2026 | News
Akso Health Group Launches Exploratory Global Patient Support Programme With Nanning Duoling Research Institute To Expand Zero Cost Cancer Care Access
Akso Health Group (NASDAQ: AHG) ("Akso Health" or the "Company") announced the launch of the an exploratory patient support program and a strategic coopera...
February 05, 2026 | News
Closing Asia’s Cancer Evidence Gap Through Translational Science And Policy Leadership
In this BioPharma APAC interview, Dr Yun Yen, Program Committee Chair for the 2026 ASCO Breakthrough meeting, shares a candid translational...
February 02, 2026 | Expert Insight
Mabwell Doses First Patient In United States First In Human Trial Of Novel CDH17 Targeting ADC For Gastrointestinal Cancers
Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that the first patient has been dosed...
January 26, 2026 | News
Ellipses Pharma Limited In Licences First In Class B7H3 Targeted ADC From Innolake Biopharm Co. Ltd To Expand Global Oncology Pipeline
Ellipses Pharma Limited (“Ellipses”), a clinical-stage oncology drug development company with a pipeline of innovative programmes, announced th...
January 26, 2026 | News
Japan’s Daiichi Sankyo Strengthens Oncology Commitment With Toronto Headquarters
Investment in Canadian headquarters fuels expansion of Canadian operations, advancing access to innovative cancer medicines Daiichi Sankyo (TSE: 4568)...
January 23, 2026 | News
D3 Bio Secures FDA IND Clearances To Advance KRAS G12D And G12C Clinical Programme
D3 Bio, a global clinical‑stage biotechnology company focused on developing transformative oncology therapeutics, announced that the U.S. Foo...
January 20, 2026 | News
Bio Sourcing And Zerion Pharma Secure Eurostars Funding To Develop Oral Trastuzumab For HER2 Breast Cancer
Bio‑Sourcing and Zerion Pharma A/S announce that their joint project to develop an oral formulation of Trastuzumab, the pioneer monoclonal antibody...
January 16, 2026 | News
Management of Relapsed/Refractory Multiple Myeloma
Doctors and researchers have made huge steps in treating this blood cancer lately. Yet, most people face a time when the cancer returns or stops responding...
January 14, 2026 | News
Pierre Fabre Laboratories And Iktos Launch AI Driven Oncology Drug Discovery Alliance
Pierre Fabre Laboratories and Iktos, a global leader in Artificial Intelligence (AI) and Robotics on drug discovery, announced an integrated drug disc...
January 12, 2026 | News
Johnson And Johnson Amivantamab Combo Delivers 73% Response Rate In First Line Metastatic Colorectal Cancer
Over 70 percent of patients in the first-line subgroup responded to amivantamab plus chemotherapy with most responses lasting beyond 16 months Notable res...
January 12, 2026 | News
UP Oncolytics Wins $75,000 Illinois Innovation Voucher To Advance Breakthrough Glioblastoma Therapy
UP Oncolytics, a biotech company in Rosalind Franklin University's Helix 51 biomedical incubator, was awarded an Illinois Innovation Voucher gran...
January 09, 2026 | News
Leading the Future of Care: Patient Organizations Driving Health System Transformation
Real Change Starts with Listening Across the Asia Pacific, Middle East, and Africa, healthcare systems are facing mounting pressures with rising rates of ...
January 05, 2026 | Opinion | By Sung Lee, Executive Director, Region Communications and Patient Advocacy, Asia Pacific, Middle East, Africa (APMA), Novartis
Harbour BioMed Partners With Lannacheng To Advance Next Generation Radionuclide Drug Conjugates
Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunolo...
January 02, 2026 | News
Most Read
- How Does GLP-1 Work?
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
